Industrial • NYSE
According to Zyberno, CRANE COMPANY (CR) is not a buy — GOOD BUSINESS (71/100) with a negative Margin of Safety of -4.9% and a Brina Gap of -15.4% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, CRANE COMPANY (CR) trades at $206.96 against an estimated intrinsic value per share of $197.22 — a -4.9% Margin of Safety based on Owner Earnings of $365.70M TTM, projected at 72.8% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -15.4% weakens the case: based on the company's ROIC (11.9%) and reinvestment rate (1.0%), the business can fundamentally grow at 0.1% — but the current enterprise value implies the market expects 15.5%. This places CR in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 18.8% annually.
Over the trailing twelve months, CR generated $365.70M in Owner Earnings. Capital was deployed as follows: $55.90M paid as dividends, $50.00M invested in capital expenditures. Reinvestment rate: 1.0%. Owner Earnings have grown at 72.8% annually over the trailing five years using log-linear regression.